Previous Article | Next Article 
Infection and Immunity, November 2003, p. 6270-6278, Vol. 71, No. 11
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.11.6270-6278.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
DNA Immunization with the Gene Encoding P4 Nuclease of Leishmania amazonensis Protects Mice against Cutaneous Leishmaniasis
Kimberly Campbell,1 Hong Diao,1 Jiaxiang Ji,1 and Lynn Soong1,2*
Departments of Microbiology and Immunology,1
Pathology, Sealy Center for Biodefense and Emerging Infectious Diseases, Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas 77555-10702
Received 27 May 2003/
Returned for modification 4 July 2003/
Accepted 8 August 2003
Infection with the protozoan parasite Leishmania amazonensis can cause diverse clinical forms of leishmaniasis. Immunization with purified P4 nuclease protein has been shown to elicit a protective response in mice challenged with L. amazonensis and L. pifanoi. To explore the potential of a DNA-based vaccine, we tested the L. amazonensis gene encoding P4 nuclease as well as adjuvant constructs encoding murine interleukin-12 (IL-12) and L. amazonensis HSP70. Susceptible BALB/c mice were immunized with the DNA encoding P4 alone, P4/IL-12, or P4/HSP70 prior to challenge with L. amazonensis promastigotes. Mice given P4/IL-12 exhibited no lesion development and had a 3- to 4-log reduction in tissue parasite burdens compared to controls. This protection corresponded to significant increases in gamma interferon and tumor necrosis factor alpha production and a reduction in parasite-specific immunoglobulin G1, suggesting an enhancement in Th1 responses. Moreover, we immunized mice with the L. amazonensis vaccines to determine if this vaccine regimen could provide cross-protection against a genetically diverse species, L. major. While the P4/HSP70 vaccine led to self-healing lesions, the P4/IL-12 vaccine provided negligible protection against L. major infection. This is the first report of successful use of a DNA vaccine to induce protection against L. amazonensis infection. Additionally, our results indicate that different vaccine combinations, including DNA encoding P4, HSP70, or IL-12, can provide significant protection against both Old World and New World cutaneous leishmaniasis.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Texas Medical Branch, Medical Research Building, 3.132, 301 University Blvd., Galveston, TX 77555-1070. Phone: (409) 772-8149. Fax: (409) 747-6869. E-mail:
lysoong{at}utmb.edu.
Editor: W. A. Petri, Jr.
Infection and Immunity, November 2003, p. 6270-6278, Vol. 71, No. 11
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.11.6270-6278.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Vasquez, R. E., Xin, L., Soong, L.
(2008). Effects of CXCL10 on Dendritic Cell and CD4+ T-Cell Functions during Leishmania amazonensis Infection. Infect. Immun.
76: 161-169
[Abstract]
[Full Text]
-
Coler, R. N., Goto, Y., Bogatzki, L., Raman, V., Reed, S. G.
(2007). Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+ T Cells. Infect. Immun.
75: 4648-4654
[Abstract]
[Full Text]
-
Joshi, M. B., Dwyer, D. M.
(2007). Molecular and Functional Analyses of a Novel Class I Secretory Nuclease from the Human Pathogen, Leishmania donovani. J. Biol. Chem.
282: 10079-10095
[Abstract]
[Full Text]
-
Martins, D. R. A., Jeronimo, S. M. B., Donelson, J. E., Wilson, M. E.
(2006). Leishmania chagasi T-Cell Antigens Identified through a Double Library Screen. Infect. Immun.
74: 6940-6948
[Abstract]
[Full Text]
-
Kerepesi, L. A., Keiser, P. B., Nolan, T. J., Schad, G. A., Abraham, D., Nutman, T. B.
(2005). DNA Immunization with Na+-K+ATPase (Sseat-6) Induces Protective Immunity to Larval Strongyloides stercoralis in Mice. Infect. Immun.
73: 2298-2305
[Abstract]
[Full Text]
-
Aguilar-Be, I., da Silva Zardo, R., Paraguai de Souza, E., Borja-Cabrera, G. P., Rosado-Vallado, M., Mut-Martin, M., del Rosario Garcia-Miss, M., Palatnik de Sousa, C. B., Dumonteil, E.
(2005). Cross-Protective Efficacy of a Prophylactic Leishmania donovani DNA Vaccine against Visceral and Cutaneous Murine Leishmaniasis. Infect. Immun.
73: 812-819
[Abstract]
[Full Text]
-
VANLOUBBEECK, Y., JONES, D. E.
(2004). PROTECTION OF C3HEB/FEJ MICE AGAINST LEISHMANIA AMAZONENSIS CHALLENGE AFTER PREVIOUS LEISHMANIA MAJOR INFECTION. Am J Trop Med Hyg
71: 407-411
[Abstract]
[Full Text]
-
Vanloubbeeck, Y. F., Ramer, A. E., Jie, F., Jones, D. E.
(2004). CD4+ Th1 Cells Induced by Dendritic Cell-Based Immunotherapy in Mice Chronically Infected with Leishmania amazonensis Do Not Promote Healing. Infect. Immun.
72: 4455-4463
[Abstract]
[Full Text]
-
Pinto, E. F., Pinheiro, R. O., Rayol, A., Larraga, V., Rossi-Bergmann, B.
(2004). Intranasal Vaccination against Cutaneous Leishmaniasis with a Particulated Leishmanial Antigen or DNA Encoding LACK. Infect. Immun.
72: 4521-4527
[Abstract]
[Full Text]
-
Campbell, K., Popov, V., Soong, L.
(2004). Identification and Molecular Characterization of a Gene Encoding a Protective Leishmania amazonensis Trp-Asp (WD) Protein. Infect. Immun.
72: 2194-2202
[Abstract]
[Full Text]